Age, Male Gender, and Social Deprivation Are Associated with a Lower Rate of Insulin Pump Therapy Initiation in Adults with Type 1 Diabetes: A Population-Based Study
Abstract
Objectives: The objective of this population-based study was to identify factors associated with insulin pump therapy initiation in adults with insulin-requiring diabetes in France in 2015. Method: People with insulin-requiring diabetes and their characteristics were identified from the national health data system. Factors associated with insulin pump therapy initiation were identified by logistic regression analysis. Results: The study focused on 614,913 adults with diabetes treated by multiple daily injections before 2015: 4083 of them initiated insulin pump therapy during the year (71% of them had type 1 diabetes, T1D). Factors associated with insulin pump therapy initiation were the number of consultations with an endocrinologist within the past 2 years (2 vs. 0, odds ratio [OR] = 1.5, P P P P P P Conclusion: Predictive factors of insulin pump therapy initiation in people with insulin-requiring diabetes in 2015 in France were globally consistent with clinical practice guidelines. Age, male gender, and social deprivation are still associated with a lower rate of insulin pump therapy initiation in adults with T1D.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
These differences in insulin pump use have been observed in both countries with insulin pump funding programs (New Zealand, Denmark, France) and those without (USA, Brazil).
“These differences have been observed in both countries with insulin pump funding programs (New Zealand, Denmark, France)9–11 and those without (USA, Brazil).12 13”
From Impact of government-funded insulin pump programs on insulin pump use in Canada: a cross-sectional study using the National Diabetes Repository (2021) · cites this paper as [10]
Among adults with type 1 diabetes, individuals who are older, male, ethnic minorities, or of lower income are significantly less likely to use insulin pumps.
“Indeed, among adults with type 1 diabetes, individuals who are older, male, ethnic minorities, or of lower income are significantly less likely to use insulin pumps.9–13”
From Impact of government-funded insulin pump programs on insulin pump use in Canada: a cross-sectional study using the National Diabetes Repository (2021) · cites this paper as [10]
Cites
Tuppin, P., Rudant, J., Constantinou, P., Gastaldi‐Ménager, C., Rachas, A., de Roquefeuil, L., Maura, G., Caillol, H., Tajahmady, A., Coste, J., et al. (2017) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2017.05.004 · Cited by 904 · see citing works
Self-citationPickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 618 · see citing works
Bidmon, S., & Terlutter, R. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4127 · Cited by 389 · see citing works
Reznik, Y., Cohen, O., Aronson, R., Conget, I., Runzis, S., Castaneda, J., & Lee, S. W. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61037-0 · Cited by 233 · see citing works
Chantelau, E. A., Spraul, M., M�hlhauser, I., Gause, R., & Berger, M. (1989) · Diabetologia · doi:10.1007/bf00271261 · Cited by 121 · see citing works
Pickup, J. C., Reznik, Y., & Sutton, A. J. (2017) · Diabetes Care · doi:10.2337/dc16-2201 · Cited by 93 · see citing works
Kalantar‐Zadeh, K., Derose, S. F., Nicholas, S., Benner, D. A., Sharma, K., & Kovesdy, C. P. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.11.012 · Cited by 85 · see citing works
Lassmann-Vague, V., Clavel, S., Guerci, B., Hanaire, H. P., Leroy, R., Loeuille, G., Mantovani, I., Pinget, M., Renard, É., & Tubiana‐Rufi, N. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.09.002 · Cited by 56 · see citing works
Vigersky, R. A., Huang, S., Cordero, T. L., Shin, J., Lee, S. W., Chhabra, H., Kaufman, F. R., & Cohen, O. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0234 · Cited by 43 · see citing works
Finding the right route for insulin delivery – an overview of implantable pump therapy
Bally, L., Thabit, H., & Hovorka, R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1267138 · Cited by 33 · see citing works
Helve, E., Koivisto, V. A., Lehtonen, A., Pelkonen, R., Huttunen, J. K., & Nikkilä, E. A. (1987) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1987.tb03360.x · Cited by 32 · see citing works
Kekäläinen, P., Juuti, M., Walle, T., & Laatikainen, T. K. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0165 · Cited by 29 · see citing works
Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data
Baudot, F.-O., Aguadé, A.-S., Barnay, T., Gastaldi‐Ménager, C., & Fagot‐Campagna, A. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-018-1024-9 · Cited by 27 · see citing works
Self-citationLeinung, M. C., Thompson, S., Luo, M., Leykina, L., & Nardacci, E. (2012) · Endocrine Practice · doi:10.4158/ep12104.or · Cited by 23 · see citing works
Kampmann, U., Madsen, L. R., Bjerg, L., Witte, D. R., Hasselstrøm, K., Østergård, T., Alstrup, K., Møller, M. K., Dylmer, D., & Hansen, K. W. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.042 · Cited by 19 · see citing works
Beato-Víbora, P. I., Chico, A. I., Giménez, M., Guerrero-Vázquez, R., Castellanos, R. B., Iriarte, M. J. G., Díaz-Soto, G., Merino-Torres, J. F., Moreno-Fernández, J., & Martínez‐Brocca, M. A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.009 · Cited by 18 · see citing works
Jankovec, Z., Hahn, M., Grunder, S., Lacigová, S., Cechurová, D., Krčma, M., Žourek, M., Haladová, I., & Rušavý, Z. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.09.028 · Cited by 17 · see citing works
Indications for Insulin Pump Therapy in Type 1 Diabetes and Associations With Glycemic Control
JENDLE, J. H., Rawshani, A., Svensson, J., Avdic, T., & Guðbjörnsdóttir, S. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816650209 · Cited by 17 · see citing works
Exploring the determinants of endocrinologist visits by patients with diabetes
Andrade, L. F., Rapp, T., & Sevilla‐Dedieu, C. (2016) · The European Journal of Health Economics · doi:10.1007/s10198-016-0794-1 · Cited by 16 · see citing works
Ribeiro, M. E. B., Liberatore, R. D. R., Custódio, R. J., & Martinelli, C. E. (2015) · Revista Paulista de Pediatria (English Edition) · doi:10.1016/j.rppede.2015.06.019 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Fallon, C., Jones, E., Oliver, N. S., Reddy, M., & Avari, P. (2022) · Diabetic Medicine · doi:10.1111/dme.14906 · Cited by 52 · see citing works
Prévost, M. S., RABASA-LHORET, R. P. R., Talbo, M. K., Yardley, J. E., Curry, E., & Brazeau, A. (2022) · Diabetes Care · doi:10.2337/dc21-1899 · Cited by 30 · see citing works
Auzanneau, M., Eckert, A. J., Meyhöfer, S. M., Heni, M., Gillessen, A., Schwettmann, L., Jehle, P. M., Hummel, M., & Holl, R. W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1191138 · Cited by 16 · see citing works
Buschur, E., Campbell, K. R., Pyle, L. L., Garcetti, R., Joshee, P., Demmitt, J. K., Snell‐Bergeon, J. K., & Polsky, S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0138 · Cited by 15 · see citing works
Madani, S., Setudeh, A., Aghayan, H. R., Alavi-Moghadam, S., Rouhifard, M., Rezaei, N., Rostami, P., Mohsenipour, R., Amirkashani, D., Bandarian, F., et al. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00837-9 · Cited by 14 · see citing works
Song, C., Booth, G. L., Perkins, B. A., & Weisman, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002371 · Cited by 12 · see citing works
Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four Decades
BUDHRAM, D. R., Bapat, P., BAKHSH, A. M. K., Abuabat, M. I., Verhoeff, N. J., Mumford, D., Cheema, W., Orszag, A., JAIN, A., Cherney, D. Z. I., et al. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0272 · Cited by 11 · see citing works
Social deprivation and exclusion in Parkinson’s disease: a cross-sectional and longitudinal study
Heimrich, K. G., Schönenberg, A., & Prell, T. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074618 · Cited by 10 · see citing works
Structural basis for regulation in gram-negative bacterial citrate synthases.
Duckworth, H. W., Anderson, D. H., Bell, A. W., Donald, L. J., Chu, A. L., & Brayer, G. D. (1987) · PubMed · Cited by 10 · see citing works
Soliman, Y., Everett, K., Shulman, R. M., Austin, P. C., Lipscombe, L. L., Booth, G. L., & Weisman, A. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15799 · Cited by 9 · see citing works
Hankosky, E. R., Katz, M. L., Fan, L., Liu, D., Chinthammit, C., Brnabic, A. J. M., & Eby, E. L. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2205795 · Cited by 7 · see citing works
Conti, M., Gironi, I., Meneghini, E., Mion, E., Vieste, G. D., Bertuzzi, F., & Pintaudi, B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14248823 · Cited by 4 · see citing works
Taras, M. A., & Pellegrini, A. (2021) · Diabetology · doi:10.3390/diabetology2040019 · Cited by 3 · see citing works
Soliman, Y., Everett, K., Shulman, R. M., Austin, P. C., Lipscombe, L. L., Booth, G. L., & Weisman, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16547 · Cited by 2 · see citing works
Qin, L., Ma, W., Cui, S., Du, Y., Lian, L., & Jin, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113022 · Cited by 2 · see citing works
Automated insulin delivery for people living with Type 1 Diabetes in France: A long road ahead
Amadou, C., & Penfornis, A. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101642 · Cited by 2 · see citing works
Self-citationJeandidier, N., Bagel, A., Bonin, A., Guigand, G., & Guerci, B. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01814-8 · Cited by 1 · see citing works
Parimi, N., Wu, C., Ziglar, J., Brown, E. A., Sidhaye, A. R., Mathioudakis, N. N., & Wolf, R. M. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261426387 · Cited by 1 · see citing works
Timing of insulin pump initiation among individuals with type 1 diabetes in Ontario, Canada
Zhu, X., Lipscombe, L. L., Shulman, R. M., Lovblom, L. E., Everett, K., & Weisman, A. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70514 · Cited by 1 · see citing works
Gargouri, I., Inna, A. A. H., Franc, S., Picaud, P., Penfornis, A., & Amadou, C. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.12.008 · Cited by 1 · see citing works
Self-citationCourtney, A., Comerford, S., & Owens, L. A. (2026) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-04245-3
Diabetes Technology: Continuous Glucose Monitoring and Insulin Delivery
MacLeod, J., Willis, H. J., Sulik, B., & Chomko, M. (2026) · American Diabetes Association eBooks · doi:10.2337/9781580408493-ch08
- Authors
- Meunier, L., Aguadé, A.-S., Videau, Y., Verboux, D., Fagot-Campagna, A., Gastaldi-Menager, C., & Amadou, C.
- Affiliations
- l'Assurance Maladie (FR)
- Université Paris-Est Créteil (FR)
- CNAM (Caisse Nationale d'Assurance Maladie), French National Health Insurance, Paris, France.
- Université Paris-Saclay (FR)
- Corresponding author
- Amadou, Coralie
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2020-12-31
- Volume
- 23
- Issue
- 1
- Pages
- 8-19
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W3033020029
- Cited by
- 22
- References
- 20
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 5
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Technology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- insulin pump therapy, type 1 diabetes, type 2 diabetes, insulin-treated diabetes, treatment initiation, social deprivation, age, male gender, cardiovascular comorbidity, end-stage renal disease, diabetes duration, health disparities
- MeSH terms
- Adult, Age Factors, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Humans, Insulin, Insulin Infusion Systems, Male, Sex Factors, Social Isolation, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
